Bioinformatics Analysis Reveals Potential Candidate Drugs for Cervical Cancer.

Zhihong Ai,Juan Wang,Yanli Xu,Yincheng Teng
DOI: https://doi.org/10.1111/jog.12022
2013-01-01
Journal of Obstetrics and Gynaecology Research
Abstract:AIM:We sought to explore the mechanisms of cervical carcinoma response to epidermal growth factor (EGF), and then identify biologically active small molecules capable of targeting the sub-pathways that were dysregulated in cervical cancer cells in the response to EGF.MATERIAL AND METHODS:Differentially expressed genes and pathways were analyzed based on the transcription profile of GSE6783, and then the differentially expressed molecules were further analyzed by several bioinformatics methods.RESULTS:Our results suggested that EGF could promote cervical cancer cell proliferation through triggering the dysregulation of certain sub-pathways in the mitogen-activated protein kinase signaling pathway, p53 signaling pathway and pathways in cancer. Furthermore, our bioinformatics analysis revealed a total of 49 small molecules which may play a role in perturbing the response to EGF of cervical cancer cells.CONCLUSIONS:Candidate drugs identified by our approach may provide the groundwork for a combination therapy approach for cervical cancer; however, further studies are still needed to make sure that the use of parthenolide or other anti-cancer agents is effective without inhibiting important host defense mechanisms in cervical cancer.
What problem does this paper attempt to address?